Tech Company Financing Transactions

Arbor Vita Funding Round

Arbor Vita, operating out of Fremont, received $2 million in investment from BDC Venture Capital and private investors.

Transaction Overview

Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
48371 Fremont Blvd. 101
Fremont, CA 94538
USA
Email Address
Overview
Arbor Vita is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs and diagnostics addressing disease through a new family of targets, PDZ proteins. PDZ proteins are critical elements that organize and regulate many signaling pathways in human cells.
Profile
Arbor Vita LinkedIn Company Profile
Social Media
Arbor Vita Company Twitter Account
Company News
Arbor Vita News
Facebook
Arbor Vita on Facebook
YouTube
Arbor Vita on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Lu
  Peter Lu LinkedIn Profile  Peter Lu Twitter Account  Peter Lu News  Peter Lu on Facebook
Chief Scientific Officer
Johannes Schweizer
  Johannes Schweizer LinkedIn Profile  Johannes Schweizer Twitter Account  Johannes Schweizer News  Johannes Schweizer on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2005: Stelar Tools venture capital transaction
Next: 6/30/2005: Vivant Medical venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary